Business
Partnership with St. Joseph's Health
Partnership with St. Joseph's Health.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 7276R\n Renalytix PLC\n 09 November 2021\n \n \n \n \n \n \n \n Renalytix plc\n \n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n St. Joseph's Health and Renalytix Partner to Advance Value-Based Kidney Health \n \n \n in New York\n \n \n \n \n \n Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease \n \n \n \n \n \n \n NEW YORK, November 9, 2021 \n \n - St. Joseph's Health and \n \n Renalytix plc\n \n (NASDAQ: RNLX) (LSE: RENX) \n today announced a partnership to implement an advanced clinical care model designed to improve kidney health in patients with type 2 diabetes and early-stage chronic kidney disease. The Renalytix KidneyIntelX™ platform will be integrated with St. Joseph's Health care management to help prevent patients with diabetes and early-stage kidney disease from unnecessarily progressing to significant disease and/or kidney failure. KidneyIntelX is designed to enable primary care and specialist physicians to easily understand risk and implement St. Joseph's Health medication management, nutrition and education intervention protocols on a timely basis. \n \n \n \n \n \n St. Joseph's Health is part of Trinity Health, one of the largest multi-institutional Catholic health care delivery systems in the U.S., serving diverse communities that include more than 30 million people across 25 states. KidneyIntelX test risk assessment will be available through St. Joseph's Hospital's electronic health record (EHR) system, providing access to primary care physicians, endocrinologists, nephrologists, and care teams. \n \n \n \n \n \n \n \"A challenge in healthcare is that approximately 35 million people have been diagnosed with diabetes and 20% of those patients with diabetes will progress to kidney failure. The Renalytix IVD test is the first tool to enable early-stage progression risk assessment in early diabetic kidney disease,\"\n \n \n \n said Paul Fiacco, MD, Medical Director, Trinity Health Integrated Care ACO and President of CNY AIM (a clinically integrated network affiliated with St. Joseph's Health).\n \n \n \n \"This risk assessment allows primary care clinicians to provide early intervention to their identified high-risk patient...